Literature DB >> 3948128

Treatment-related white matter changes in cancer patients.

Y Y Lee, C Nauert, J P Glass.   

Abstract

Forty cancer patients with bilateral diffuse cerebral white matter hypodensities on computerized tomography (CT) scan were reviewed. Brain irradiation and/or chemotherapy were considered responsible for the CT abnormalities in all patients but one, whose changes were presumably due to demyelination related to the aging process. Among these 39 patients, 7 had clinical symptoms of leukoencephalopathy. Two patients had acute transient leukoencephalopathy, and one of them experienced permanent neurologic changes after continuing treatment. Six additional patients had delayed leukoencephalopathy. The interval between whole-brain irradiation (WBXRT) alone and the CT detection of white matter hypodensities was almost always longer than 1 year. This interval was shortened to less than 1 year in a significant number of patients when WBXRT was followed by various chemotherapeutic protocols. More importantly, there was an increased incidence of clinical leukoencephalopathy. A higher incidence of clinical leukoencephalopathy in patients receiving intracarotid chemotherapy in the treatment of brain tumors and in patients receiving combination chemotherapy for central nervous system relapse of adult leukemia suggests a need for further investigation.

Entities:  

Mesh:

Year:  1986        PMID: 3948128     DOI: 10.1002/1097-0142(19860415)57:8<1473::aid-cncr2820570807>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  Treatments for astrocytic tumors in children: current and emerging strategies.

Authors:  Stanislaw R Burzynski
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

2.  Early volume reduction of the hippocampus after whole-brain radiation therapy: an automated brain structure segmentation study.

Authors:  Yohei Takeshita; Keita Watanabe; Shingo Kakeda; Toshihiko Hamamura; Koichiro Sugimoto; Hiromi Masaki; Issei Ueda; Natsuki Igata; Takayuki Ohguri; Yukunori Korogi
Journal:  Jpn J Radiol       Date:  2019-10-29       Impact factor: 2.374

3.  Intracerebral (parenchymal) infusion of methotrexate: report of a case.

Authors:  K A Page; H Vogel; D S Horoupian
Journal:  J Neurooncol       Date:  1992-02       Impact factor: 4.130

4.  Quality of life in brain tumor patients.

Authors:  A R Giovagnoli; M Tamburini; A Boiardi
Journal:  J Neurooncol       Date:  1996-10       Impact factor: 4.130

5.  Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment.

Authors:  R S Scheibel; C A Meyers; V A Levin
Journal:  J Neurooncol       Date:  1996-10       Impact factor: 4.130

6.  White matter changes on magnetic resonance imaging following whole-brain radiotherapy for brain metastases.

Authors:  Osamu Fujii; Kayoko Tsujino; Toshinori Soejima; Eisaku Yoden; Yukako Ichimiya; Kazuro Sugimura
Journal:  Radiat Med       Date:  2006-06

7.  Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy.

Authors:  Michael J Petr; Christopher M McPherson; John C Breneman; Ronald E Warnick
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 8.  A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy.

Authors:  Carol L Armstrong; Kunsang Gyato; Abdel W Awadalla; Robert Lustig; Zelig A Tochner
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

9.  Cognitive impairment and quality of life in long-term survivors of malignant brain tumors.

Authors:  A R Giovagnoli; A Boiardi
Journal:  Ital J Neurol Sci       Date:  1994-12

10.  Early and late stage positron emission tomography (PET) studies on the haemocirculation and metabolism of seemingly normal brain tissue in patients with gliomas following radiochemotherapy.

Authors:  K Mineura; Y Suda; T Yasuda; M Kowada; T Ogawa; F Shishido; K Uemura
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.